Myriad Genetics, Inc. (MYGN) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Myriad Genetics, Inc. (MYGN) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS


Myriad Genetics, Inc. issued its quarterly earnings results on Tuesday. The company reported $0.26 EPS for the quarter, topping the Zacks' consensus estimate of $0.24 by $0.02.



from Biotech News